| 12318458 |
PSMA-targeting ligands with optimal properties for imaging and therapy |
Reinier Hernandez |
2025-06-03 |
|
| 12156921 |
PSMA-targeting ligands with optimal properties for imaging and therapy |
Reinier Hernandez |
2024-12-03 |
|
| 12109256 |
Radiohalogenated agents for in situ immune modulated cancer vaccination |
Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz |
2024-10-08 |
|
| 11739174 |
Cationic cyclic amine and amphipathic transfection reagents |
Nicholas A. A. Rossi, Karen Neder, James Ludtke, Laura Juckem |
2023-08-29 |
|
| 11730834 |
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination |
Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz +1 more |
2023-08-22 |
|
| 11623007 |
Long-lived gadolinium based tumor targeted imaging and therapy agents |
Jamey P. Weichert, Wolfgang Axel Tomé |
2023-04-11 |
|
| 11467159 |
Luminescent phospholipid analogs for the identification and isolation of circulating tumor cells |
Jamey P. Weichert, Chorom Pak, Kevin Kozak, Marc Longino |
2022-10-11 |
$287,000 |
| 11439709 |
Phospholipid ether analogs as cancer-targeting drug vehicles |
Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more |
2022-09-13 |
$561,000 |
| 11186598 |
Radioactive phospholipid metal chelates for cancer imaging and therapy |
Jamey P. Weichert, Reinier Hernandez |
2021-11-30 |
|
| 10813998 |
Long-lived gadolinium based tumor targeting imaging and therapy agents |
Jamey P. Weichert, Wolfgang Axel Tomé |
2020-10-27 |
|
| 10751430 |
Targeted radiotherapy chelates for in situ immune modulated cancer vaccination |
Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz +1 more |
2020-08-25 |
|
| 10736949 |
Radiohalogenated agents for in situ immune modulated cancer vaccination |
Jamey P. Weichert, Paul Sondel, Zachary Morris, Mario Otto, Bryan Bednarz |
2020-08-11 |
|
| 10265398 |
Long-lived gadolinium based tumor targeted imaging and therapy agents |
Jamey P. Weichert, Wolfgang Axel Tomé |
2019-04-23 |
|
| 10004818 |
Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer |
Jamey P. Weichert, Irawati Kandela, Marc Longino, William R. Clarke |
2018-06-26 |
|
| 9925269 |
Phospholipid ether analogs as cancer-targeting drug vehicles |
Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more |
2018-03-27 |
$272,000 |
| 9616140 |
Fluorescent phospholipid ether compounds, compositions, and methods of use |
Jamey P. Weichert, Marc Longino, Irawati Kandela, William R. Clarke |
2017-04-11 |
$1,705,000 |
| 9579406 |
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
Jamey P. Weichert, Marc Longino |
2017-02-28 |
$1,546,000 |
| 9550002 |
Phospholipid analogs as diapeutic agents and methods thereof |
Jamey P. Weichert, Marc Longino |
2017-01-24 |
$891,000 |
| 9480754 |
Phospholipid ether analogs as cancer-targeting drug vehicles |
Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more |
2016-11-01 |
$596,000 |
| 9345718 |
Phospholipid ether analogs as cancer-targeting drug vehicles |
Jamey P. Weichert, Kevin Kozak, Marc Longino, Joseph Grudzinski, Benjamin Titz +2 more |
2016-05-24 |
$1,057,000 |
| 9339564 |
Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer |
Jamey P. Weichert, Irawati Kandela, Marc Longino, William R. Clarke |
2016-05-17 |
|
| 8877160 |
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
Jamey P. Weichert, Marc Longino |
2014-11-04 |
|
| 8877159 |
Phospholipid analogs as diapeutic agents and methods thereof |
Jamey P. Weichert, Marc Longino |
2014-11-04 |
|
| 8871181 |
Fluorescent phospholipid ether compounds, compositions, and methods of use |
Jamey P. Weichert, Marc Longino, Irawati Kandela, William R. Clarke |
2014-10-28 |
|
| 8540968 |
Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
Jamey P. Weichert, Marc Longino |
2013-09-24 |
|
